Last update 10 May 2025

JD-023

Overview

Basic Info

Drug Type
CAR-NK
Synonyms
CD123 CAR-NK cells(Beijing JD Biotech), JD023
Target
CD123
Action
inhibitors
Mechanism
CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
CD123 Positive Acute Myeloid LeukemiaRelapsing acute myeloid leukemia
Inactive Indication-
Originator Organization
Beijing Jingda Biotechnology Co., Ltd.Beijing Jingda Biotechnology Co., Ltd.
Active Organization
Beijing Jingda Biotechnology Co., Ltd.Beijing Jingda Biotechnology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseEarly Phase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with JD-023
NCT05574608
/ RecruitingEarly Phase 1IIT
Early Clinical Study of Allogenic CD123-CAR-NK Cells (JD023 Injection) in the Treatment of Refractory or Relapsed CD123-positive Acute Myeloid Leukemia
100 Clinical Results associated with JD-023
Login to view more data
100 Translational Medicine associated with JD-023
Login to view more data
100 Patents (Medical) associated with JD-023
Login to view more data
100 Deals associated with JD-023
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CD123 Positive Acute Myeloid LeukemiaPhase 1
China
Beijing Jingda Biotechnology Co., Ltd.Beijing Jingda Biotechnology Co., Ltd.
01 Oct 2022
Relapsing acute myeloid leukemiaPhase 1
China
Beijing Jingda Biotechnology Co., Ltd.Beijing Jingda Biotechnology Co., Ltd.
01 Oct 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free